Bioage Labs Inc BIOA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $11.27
- Day Range
- $11.23–11.94
- 52-Week Range
- $4.25–25.96
- Bid/Ask
- $11.50 / $11.90
- Shares Outstanding
- 45.90M
- Market Cap
- $537.91M
- Volume/Avg
- 953,528 / 806,581
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 45.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 62
- Website
- https://www.bioagelabs.com
Valuation
|
Metric
|
BIOA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.43 |
Price/Sales | 45.09 |
Price/Cash Flow | — |
Price/Earnings
BIOA
Financial Strength
|
Metric
|
BIOA
|
|---|---|
Quick Ratio | 16.62 |
Current Ratio | 17.19 |
Interest Coverage | −380.22 |
Quick Ratio
BIOA
Profitability
|
Metric
|
BIOA
|
|---|---|
Return on Assets (Normalized) | −23.26% |
Return on Equity (Normalized) | −24.98% |
Return on Invested Capital (Normalized) | −28.35% |
Return on Assets
BIOA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|lrQ?bBhs | LOCK|?&t?& | $72B | |||
| Haleon PLC ADR
HLN
| LOCK|r#hg^@ | LOCK|^? | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|W^?S<>LX | LOCK|rjv&n | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|k%p&!$@! | LOCK|WD# | $30B | |||
| Viatris Inc
VTRS
| LOCK|dN!P&ks | LOCK|&Q% | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|n!> | LOCK|vjX | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|b^<lj# | LOCK|ZV | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^^?<!B | LOCK|g#Z | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|CXdXL>s | LOCK|kr$@ | $3B | |||
| Perrigo Co PLC
PRGO
| LOCK|@jSFL& | LOCK|z^ | $2B |
United States